PolarityTE is focused on transforming the lives of patients by discovering, designing and developing a range of regenerative tissue products and biomaterials for the fields of medicine, biomedical engineering and material sciences. Rather than manufacturing with synthetic and foreign materials within artificially engineered environments, PolarityTE manufactures products from the patient's own tissue and uses the patient's own body to support the regenerative process. From a small piece of healthy autologous tissue, the company creates dynamic and self-propagating products designed to regenerate the target tissues. PolarityTE's innovative method is intended to promote and accelerate growth of the patient's tissues to undergo a form of effective regenerative healing. The company’s first marketed product, SkinTE is the first and only Food and Drug Administration (FDA)-registered product to achieve complete tissue regeneration. SkinTE is an autologous (from the patient, for the patient) skin product designed to regrow full-thickness skin to repair, reconstruct or replace a patient's damaged or missing skin tissue.